Navigation Links
Cure For Persistent Oral Fungal Problem May Be Possible

Buffalo University dental researchers have identified some proteins that have anti-fungal properties and have the //potential to replace current drugs that are used to treat fungal infections of the mouth.

These peptides have strong anti-fungal properties, even against fungal infections that become resistant to medication. Also the properties of these peptides can be increased if they can be protected from the enzymes that may destroy them.

This may be achieved by synthesizing a protease inhibitor cocktail that may inhibit the enzymes that kill the peptides. This cocktail thus may be able to increase the ability of the peptides to treat potential oral infections up to double their original power.

One peptide called MUC7 12-mer, which occurs naturally in the human salivary mucin molecule is quite effective for treating oral fungal infections. Even active in very low concentrations, when used with inhibitors, the peptide killed the fungal agents that cause very common infections like candidiasis and cryptococcosis. These can be an especially effective treatment for patients having immunity suppressing drugs, like those suffering from HIV-AIDS, Organ transplant patients and chemotherapy patients.

http://www.buffalo.edu/news/fast-execute.cgi/article-
page.html?article=66080009
'"/>




Page: 1

Related medicine news :

1. Persistent Childhood Wheeze Probably Inherited
2. Persistent Fatigue Could Be An Early Indicator Of Postpartum Depression
3. Women More Persistent with Monthly Osteoporosis Treatment
4. Insurance Data Show High Costs of Persistent Asthma
5. Fungal Infections Effectively Controlled By Light Therapy
6. Fungal spores in the pillows can trigger an asthma attack
7. Immunosuppressive Action Of Fungal Metabolite - Gliotoxin
8. Fungal toxins infected corn the reason for congenital defects
9. Contact Lenses Implicated in Fungal Infections
10. Spread Of Fungal Infections At Gym Could Be Avoided By Using Towel
11. Lens Wearers Alerted Over Dangerous Fungal Infection

Post Your Comments:
(Date:11/9/2009)...drugs that inhibit estrogen, , , MONDAY...at breast cancer and osteoporosis eliminated cervi... The drugs also cleared precancerous growths in th...ncer in mice with precancerous lesions. , The b...r/osteoporosis drug raloxifene were given to mice ...
(Date:11/9/2009)...equally, study finds, , , MONDAY, Nov. ...ing drug Plavix (clopidogrel) works about the same... trials has found. , "After this study, I can s...men with this very important drug," said Dr. Jeffr...s at New York University Langone Medical Center in...
(Date:11/9/2009)...g is everybody,s buzz word today and for Recruiter...ables Recruiters and Staffers create their own pri...icate and close positions. The site also enables i...etwork with recruiters. , ...rces everyone to network more than ever and by the...
(Date:11/9/2009)... could boost self-esteem, researchers say , ...children are more likely to have handwriting probl... without autism, researchers say. , The new stu... study participants had autism spectrum disorder, ...ange for perceptual reasoning on an IQ test. , ...
(Date:11/9/2009)...gained sexual function, study says, , ...were able to restore sexual function to rabbits wi... the lab and implanting it, a new study reports. ,...archers say the technique could one day be used to...e were able to show the tissue was able to integra...
Breaking Medicine News(10 mins):Health News:Breast Cancer Drugs May Fight Cervical Cancer, Too 2Health News:No Gender Gap Found for Clot-Busting Drug 2Health News:No Gender Gap Found for Clot-Busting Drug 3Health News:Launching StaffingClub.com, a New Online Networking Platform for Recruiting and Staffing Professionals 2Health News:Handwriting Skills May Lag in Kids With Autism 2Health News:Scientists Grow New Penile Tissue in the Lab 2Health News:Scientists Grow New Penile Tissue in the Lab 3
...nt headaches that they suffer from are connected t...hers. //The pediatric neurologist Kenneth Mack led...ds of the children studied who suffer from chronic...eep problems. Dr Mack said that the researc...
... earth to slip westward, according to a study by I...lished by the Bulletin of the Geological Society o...University and his team of Italian and US scientis...producing earthquakes, mountains and rifts where t...
...foot', an ape-like beast in the Johor forests of M...//This has been done on the request of the authori...Singapore Paranormal Investigators (SPI). The medi...he creatures, reportedly three meters tall are rep...
...e contact with sick birds has died of what is thou... Health authorities at Jakarta's Infectious Diseas...ried the virus. Blood and swab samples have been s... The WHO is calling for preventive measures in...
...h, the World Health Organization and UNAIDS on the...y, //is raising doubts over the numbers that are b... A report released in 2003 had put the number...0. The report also says that in the last year ther...
... introduce a Pilot scheme called 'Primary Care Cen...ting to avail health care facilities in big hospit...nts to see their physician in outpatient facility ...hich does not require long waiting hours and journ...
Other Medicine News:Health News:Headaches Among Children And Sleep Problems Are Interrelated 2
(Date:11/9/2009)...NWOOD, Ill., Nov. 9 Lan... personal and environmental radiation monitoring s...uisitions in accordance with its long-term strateg...he acquisitions of Global Physics Solutions, Inc. ...l Saxelby, President and CEO of Landauer. "These a...
(Date:11/9/2009)...DCLIFF LAKE, N.J., Nov. 9 /PRNewswire-FirstCall/ -... today announced that it has extended the expirati...eviously announced "Modified Dutch Auction" tender...cash, up to $65,000,000 aggregate principal amount... 2.875% Senior Subordinated Convertible Notes due ...
(Date:11/9/2009)...KVILLE, Md., Nov. 9 OriGene Techno...chnology in Sweden has adopted its VERIFY Tagged A...Protein Atlas program. This program is funded by t... up to explore the human proteome systematically u...uality mono-specific antibodies in a high throughp...
Breaking Medicine Technology:Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 2Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 3Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 4Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market 5Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Royal Institute of Technology Adopts OriGene Over-Expression Lysates in Human Proteome Atlas Program 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 1Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 2Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 3Stereotaxis Showcases Interventional Value of Magnetic Navigation at TCT 2009 58241 430th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 130th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 230th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 330th Anniversary Edition of Mandell Douglas and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever 58240 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 1Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 2Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 3Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 4Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 5Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 6Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 7Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 8Vectibix 28R 29 in Combination With Chemotherapy Significantly Improves Progression Free Survival in First Line Metastatic Colorectal Cancer 5052 9
...euticals (Nasdaq: VIAP ), a biotechnology company...reatment of cardiovascular disease,announced today... (DSMB),for its VIA-2291 Phase 2 clinical trial pr...s current Phase 2 studies. The DSMB observed a,con...ecommended VIA,continue its ongoing trials as plan...
...cess to FOSRENOL(R) and Resources fo...PHIA, April 3, 2008 Shire Pharmaceuticals, the,gl...e launch of On Track,an innovative program designe...ens among chronic kidney disease (CKD) Stage 5 pat...hosphorus in the blood). In addition,to offering t...
Other Medicine Technology:VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 2VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 3VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 2Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 3Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 4Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 5Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 6Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 7Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients 8
Vannas Capsulotomy scissors angled forward
Vannas Capsulotomy scissors straight
Gills-Vannas straight capsulotomy flat handle scissors
Vannas side angled capsulotomy round handle scissors
Medicine Products: